RxDoctor Payments Data

Christina Rebic

Primary Care · Bedford, OHNPI 1275003964

Payments from drug & device makers

$1,078in general payments, 2019–2025

Across 57 payments — averaging $18.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$342
  • Regeneron$150
  • Pfizer$131
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$73
  • Exact Sciences$68
  • E.r. Squibb & Sons, L.L.C.$67
  • plus $247 from 9 others

What the payments were for

  • Food & beverage$1,078100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,078 in reported general payments places this provider in the 70th percentile of 321 primary care providers in Ohio.

See all primary care providers in Ohio

Medicare billing

Part B allowed, 2024
$25,482
Medicare patients
115
Services billed
357

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide33$31,543
XareltoRivaroxaban27$30,065
EliquisApixaban36$27,157
TrulicityDulaglutide17$21,103
JardianceEmpagliflozin14$16,077
JanuviaSitagliptin Phosphate13$13,762
Atorvastatin Calcium252$2,712
Gabapentin139$2,184
Albuterol Sulfate HfaAlbuterol Sulfate70$1,966
Metoprolol Succinate98$978
Testosterone11$965
Pantoprazole Sodium97$864
Levothyroxine Sodium110$803
Calcitonin-SalmonCalcitonin,salmon,synthetic15$715
Celecoxib14$692

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$38$30,06527 claims
PfizerEliquis$131$27,15736 claims
Lilly USA, LLCTrulicity$23$21,10317 claims
AbbVieSynthroid$342$57914 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 321 primary care providers in Ohio.

Other primary care in Bedford

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →